Somatic mutations in clonally amplified CD8+ lymphocyte populations in patients with rheumatoid arthritis (RA) and unique TCRβ characteristics have been detected in patients with invasive destructive RA, who express high levels of tumor necrosis factor superfamily member 14 cytokines. The gene discussed is CD8A; the disease is rheumatoid arthritis.